An Efficacy and Safety Study of intravenous Golimumab in patients with Active Rheumatoid Arthritis (RA) despite treatment with methotrexate, non steroidal pain medications and/or corticosteroids

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-006064-11

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to assess the clinical efficacy of IV administration of golimumab 2 mg/kg + MTX compared with MTX alone in subjects with active RA despite MTX therapy.


Critère d'inclusion

  • Rheumatoid arthritis (RA)